Skip To Content| Skip To Local Navigation
Gives an overview of extended-release injectable naltrexone (Vivitrol), a treatment for people with opioid dependence. Discusses how it differs from other medication-assisted treatments, safety concerns, and patients most likely to benefit from this treatment.
Federal Guidelines for Opioid Treatment Programs Provides updated guidelines for the operation of opioid treatment programs...
Advisory: Sublingual and Transmucosal Buprenorphine for Opioid Use Disorder: Review and Update Gives an overview of data on the use of sublingual and transmucosal...
MATx Mobile App by SAMHSA MATx empowers health care practitioners to provide effective, evidence-based...
Protracted Withdrawal Provides an overview of protracted withdrawal. Discusses symptoms associated...
Tobacco Use Cessation During Substance Abuse Treatment Counseling Offers addiction counselors an introduction to tobacco use cessation during...
Tobacco Use Cessation Policies in Substance Abuse Treatment: Administrative Issues Equips substance use treatment program administrators with information to...